Location: West Conshohocken, PA
CIK: 0001802528 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.384B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLTO | DAMORA THERAPEUTICS INC | 8,713,000 | $226M | 16.3% | $25.80 | 0.0% | COM NEW | 36322Q206 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 2,537,191 (+18.7%) | $213M (+141.8%) | 15.4% | $22.00 | +116.2% | COM | 252828108 |
| ZBIO | ZENAS BIOPHARMA INC | 2,359,025 (+6.8%) | $46.12M (-42.5%) | 3.3% | $20.23 | +8.2% | COM | 98937L105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 727,563 | $73.19M | 5.3% | $22.67 | +357.3% | — | 670703107 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 1,319,688 | $54.44M | 3.9% | $21.28 | +102.9% | — | G52694109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 298,647 (-85.4%) | $25.14M (-83.7%) | 1.8% | $22.03 | +227.9% | COM | 03770N101 |
| COGT | COGENT BIOSCIENCES INC | 5,503,418 (-38.9%) | $212M (-33.8%) | 15.3% | $9.55 | +291.2% | COM | 19240Q201 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,855,644 (-50.0%) | $72.74M (+27.3%) | 5.3% | $18.70 | +36.9% | COM | 29337E102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 4,018,101 | $203M | 14.6% | $31.80 | +8.6% | COM NEW | 00773J202 |
| ORKA | ORUKA THERAPEUTICS INC | 3,705,262 | $182M | 13.1% | $32.55 | -0.3% | COM | 687604108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,914,458 | $76.57M | 5.5% | $17.81 | +73.1% | COM | 92790C104 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,747,866 | $50.48M | 3.6% | $16.99 | -34.9% | COM | G2545C104 |
| JBIO | JADE BIOSCIENCES INC | 4,553,494 | $63.98M | 4.6% | $26.99 | -45.2% | COM NEW | 008064206 |
| IKT | INHIBIKASE THERAPEUTICS INC | 8,625,000 | $14.49M | 1.0% | $2.23 | -22.3% | COM NEW | 45719W205 |